UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4971-4981

2013

Link zum Volltext

Verfügbarkeit prüfen

Selective Serotonin Reuptake Inhibitor Fluoxetine Inhibits Replication of Human Enteroviruses B and D by Targeting Viral Protein 2C

Antimicrobial Agents and Chemotherapy, 2013-04, Vol.57 (4), p.1952-1956

2013

Link zum Volltext

Verfügbarkeit prüfen

Combating enterovirus replication: State-of-the-art on antiviral research

Biochemical pharmacology, 2012-01, Vol.83 (2), p.185-192

2012

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibitors of picornavirus replication

Medicinal research reviews, 2008-11, Vol.28 (6), p.823-884

2008

Link zum Volltext

Verfügbarkeit prüfen

The Crystal Structure of Coxsackievirus B3 RNA-Dependent RNA Polymerase in Complex with Its Protein Primer VPg Confirms the Existence of a Second VPg Binding Site on Picornaviridae Polymerases

Journal of Virology, 2008-10, Vol.82 (19), p.9577-9590

2008

Link zum Volltext

Verfügbarkeit prüfen

Potential use of antiviral agents in polio eradication

Emerging infectious diseases, 2008-04, Vol.14 (4), p.545-551

2008

Link zum Volltext

Verfügbarkeit prüfen

Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles

Biochemical and biophysical research communications, 2007-02, Vol.353 (3), p.628-632

2007

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1850-1857

2009

Link zum Volltext

Verfügbarkeit prüfen

The Thiazolobenzimidazole TBZE-029 Inhibits Enterovirus Replication by Targeting a Short Region Immediately Downstream from Motif C in the Nonstructural Protein 2C

Journal of Virology, 2008-05, Vol.82 (10), p.4720-4730

2008

Link zum Volltext

Verfügbarkeit prüfen

Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies

Reviews in medical virology, 2016-01, Vol.26 (1), p.21-33

2016

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles

Bioorganic & medicinal chemistry, 2008-09, Vol.18 (18), p.5123-5125

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification and Analysis of Antiviral Compounds Against Poliovirus

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1387, p.325

2016

Link zum Volltext

Verfügbarkeit prüfen

SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors

Bioorganic & medicinal chemistry letters, 2011-07, Vol.21 (14), p.4271-4275

2011

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis

Circulation (New York, N.Y.), 2006-08, Vol.114 (6), p.565-573

2006

Link zum Volltext

Verfügbarkeit prüfen

Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence

Emerging microbes & infections, 2019-01, Vol.8 (1), p.1076-1085

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel substituted 9-norbornylpurines and their activities against RNA viruses

Bioorganic & medicinal chemistry letters, 2012-03, Vol.22 (5), p.1963-1968

2012

Link zum Volltext

Verfügbarkeit prüfen

Towards the design of combination therapy for the treatment of enterovirus infections

Antiviral research, 2011-06, Vol.90 (3), p.213-217

2011

Link zum Volltext

Verfügbarkeit prüfen

Picornavirus non-structural proteins as targets for new anti-virals with broad activity

Antiviral research, 2011-03, Vol.89 (3), p.204-218

2011

Link zum Volltext

Verfügbarkeit prüfen

2′- C-Methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus

Antiviral research, 2007-03, Vol.73 (3), p.161-168

2007

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors

Bioorganic & medicinal chemistry, 2010-06, Vol.18 (12), p.4374-4384

2010

Link zum Volltext

Verfügbarkeit prüfen

The Interferon Inducer Ampligen [Poly(I)-Poly(C12U)] Markedly Protects Mice against Coxsackie B3 Virus-Induced Myocarditis

Antimicrobial Agents and Chemotherapy, 2004-01, Vol.48 (1), p.267-274

2004

Link zum Volltext

Verfügbarkeit prüfen

Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis

Virology (New York, N.Y.), 2008-12, Vol.382 (1), p.20-27

2008

Link zum Volltext

Verfügbarkeit prüfen

Norbornane as the novel pseudoglycone moiety in nucleosides

Tetrahedron, 2009-11, Vol.65 (45), p.9291-9299

2009

Link zum Volltext

Verfügbarkeit prüfen

Potential Use of Antiviral Agents in Polio Eradication

Emerging infectious diseases, 2008-04, Vol.14 (4), p.545-551

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(107)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(48)
Humans
(36)
Biological And Medical Sciences
(23)
Medical Sciences
(20)
Antiviral Agents - Pharmacology
(17)
Male
(17)
Antiviral Agents
(16)
Animals
(15)
Enterovirus
(15)
Female
(15)
Pharmacology. Drug Treatments
(15)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(14)
Pharmacology & Pharmacy
(14)
Virology
(12)
Adult
(9)
Microbiology
(9)
Middle Aged
(9)
Picornavirus
(9)
Poliovirus
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ

The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family

Selective Serotonin Reuptake Inhibitor Fluoxetine Inhibits Replication of Human Enteroviruses B and D by Targeting Viral Protein 2C

Combating enterovirus replication: State-of-the-art on antiviral research

Selective inhibitors of picornavirus replication

The Crystal Structure of Coxsackievirus B3 RNA-Dependent RNA Polymerase in Complex with Its Protein Primer VPg Confirms the Existence of a Second VPg Binding Site on Picornaviridae Polymerases

Potential use of antiviral agents in polio eradication

Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles

Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307

The Thiazolobenzimidazole TBZE-029 Inhibits Enterovirus Replication by Targeting a Short Region Immediately Downstream from Motif C in the Nonstructural Protein 2C

Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies

Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles

Identification and Analysis of Antiviral Compounds Against Poliovirus

SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors

Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis

Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence

Novel substituted 9-norbornylpurines and their activities against RNA viruses

Towards the design of combination therapy for the treatment of enterovirus infections

Picornavirus non-structural proteins as targets for new anti-virals with broad activity

2′- C-Methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus

Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors

The Interferon Inducer Ampligen [Poly(I)-Poly(C12U)] Markedly Protects Mice against Coxsackie B3 Virus-Induced Myocarditis

Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis

Norbornane as the novel pseudoglycone moiety in nucleosides

Potential Use of Antiviral Agents in Polio Eradication

Suchergebnisse filtern